Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Original Broadcast: September 17, 2022

Conference: TCT 2022

FCR Presenter: Aloke Finn

This website uses cookies to ensure you get the best experience on our website. Read More

Endovascular